Once again turning to this forum for a decision I am struggling with. I have been ADT since Oct 2019 which (maybe assisted with some lifestyle changes) has resulted in a dramatic reduction in my cancer, as verified by my CT scan last month, PSA score (<0.1), and now the MRI. As of now, there is no evidence of cancer in my body.
This MRI was done for radiation planning after I had the gold markers places in my prostate. I had the radiation simulation session on Friday, treatment starts 8th July. My radiation oncologist said that given my response to ADT, my age, and otherwise good health he is going to proceed with the planned radiation in the hopes of CURING me. That is the first time some used the word "cure" for APC. I still remember in Sept 2019, the first doc I saw after my diagnosis said, you may have just 6-months left.
The radiation oncologist said that the plan is to radiate my prostate and to give a lower dose to the lymph nodes that had shown tumors last year, which was pretty extensive, maybe over 30 lymph nodes, from below my pelvic region (thigh area) to all the way up to my rib cage.
Give the possibility of a cure, I pretty excited and cautiously optimistic. I know there are risks involved with radiation, the docs said a 50-50 chance of ED and some lower risks of additional cancers developing in 10-15 years. Given the possibility of the upside of getting off ADT for good, it makes me feel like it is worth the risk.
Am I doing the right thing taking this risk?
Have people heard of others being cured with similar lymph node involvement?
Thank you for your feedback and continued support
The MRI report is below -
MR PROSTATE WITH AND WITHOUT CONTRAST, MR 3D PROSTATE 6/22/2020 2:50 PM
COMPARISON: CT abdomen pelvis 1/20/2020. PET/CT 2/21/2020.
CLINICAL HISTORY:
55 years man with biopsy-proven prostate cancer on 10/20/2019; Gleason score = 4+5
Management = ADT and abiraterone
Most recent PSA = less than 0.1 ng/ml; PSA date = 5/29/2020
TECHNIQUE:
Multiplanar T1, T2, and diffusion weighted MR images were obtained through the pelvis on a 3 Tesla magnet using a pelvic phased array coil..Dynamic post-gadolinium images were acquired following the intravenous administration of gadolinium.
3D post-processing and segmentation of the prostate was performed in an independent workstation (DynaCAD) in preparation for possible MRI-ultrasound fusion biopsy with UroNav.
CONTRAST MEDIA: Intravenous gadolinium chelate was administered for post-contrast imaging.
FINDINGS:
Prostate volume: 23 cc
PSA density: Not applicable
Length of membranous urethra: 14 mm
Post-biopsy hemorrhage: None
Multiparametric MR evaluation:
Heterogeneous appearance of the central gland is consistent with benign prostatic hyperplasia. Diffuse low T2 signal throughout the gland extending into the bilateral seminal vesicles with thickening of the rectoprostatic fascia compatible with post-treatment change.
Capsular margin and neurovascular bundle: No evidence of macroscopic extracapsular extension.
Seminal vesicles: No evidence of seminal vesicle invasion.
Lymph nodes: No lymphadenopathy seen in the field of view.
Bones: No suspicious lesions in the field of view. Scattered bone islands and herniation pit in the right femoral neck.
Bladder: Trabeculated without focal lesions.
Rectum: Unremarkable
Other: Trace free fluid in the pelvis. Small fat-containing inguinal hernias.
IMPRESSION:
- PI-RADS v2.1 score 2: clinically significant cancer is unlikely to be present.
- Diffuse low signal throughout the gland and seminal vesicles with thickening of the rectoprostatic fascia, compatible with post-treatment change.
- No evidence of macroscopic extracapsular extension. No evidence of seminal vesicle invasion.
- No lymphadenopathy. No suspicious bone lesions.